Aptorum Group Limited

APM

$7.00

-14.84%

2026-09-04 09:30:00 EDT+$0.00

Healthcare

Biotechnology

NASDAQ

Inactive

Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to ...

Recent News of APM

GuruFocus8/25/2026Neutral

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Woodside Energy Group (ASX: WDS) (NYSE: WDS):This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824

GuruFocus8/21/2026Neutral

MHI Receives Contract for APM System at Dubai's Al Maktoum International Airport

- Delivery of the world's largest APM system for airports, supporting the airport development plan to accommodate 260 million passengers annually- MHI Group is

GuruFocus8/7/2026Neutral

Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance Amid Tariff Pressures

Revenue: $5 billion, up 4.4% on an FX-neutral basis.Adjusted Operating Margin: 24.9%, down 130 basis points versus the prior year.Adjusted Gross Margin: 54.3%,

GlobeNewsWire7/16/2026Neutral

Aptorum Group Provides Update on DiamiR Biosciences Merger

Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”

GlobeNewsWire7/8/2026Neutral

Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, July 08, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced upcoming presentations at the annual Alzheimer's Association International Conference (AAIC), taking place at the Excel London Convention & Exhibition Centre, in London, UK, and online, on July 11-15, 2026, showcasing biomarker technologies from DiamiR's CLIA-certified, CAP-accredited clinical laboratory. Alidad Mireskandari, Ph.D.

GuruFocus•8/25/2026

Woodside Energy Half-Year Report for Period Ended 30 June 2026

Woodside Energy Group (ASX: WDS) (NYSE: WDS):This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824

MHI Receives Contract for APM System at Dubai's Al Maktoum International Airport

- Delivery of the world's largest APM system for airports, supporting the airport development plan to accommodate 260 million passengers annually- MHI Group is

Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance Amid Tariff Pressures

Revenue: $5 billion, up 4.4% on an FX-neutral basis.Adjusted Operating Margin: 24.9%, down 130 basis points versus the prior year.Adjusted Gross Margin: 54.3%,

Neutral

General

APM: Neutral

GlobeNewsWire•7/16/2026

Aptorum Group Provides Update on DiamiR Biosciences Merger

Post-Merger company, Niki BioSolutions, Inc., to Trade on Nasdaq Under Ticker “NIKI”

Neutral

General

APM: Neutral

GlobeNewsWire•7/8/2026

Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference

Neutral

General

APM: Neutral

GlobeNewsWire•6/22/2026

Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs. and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced a collaboration between DiamiR and AlzLabs Precision Diagnostics (“AlzLabs”) to generate protein and microRNA blood-based biomarker data with the focus on Alzheimer's disease.

Neutral

General

APM: Neutral

Newsfile Corp•6/18/2026

Statement in Response to Silver Elephant's News Release Dated June 17, 2026

Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Andean Precious Metals Corp. (TSX: APM) (OTCQX: ANPMF) ("Andean" or the "Company") is aware of the news release issued by Silver Elephant Mining Corp. ("Silver Elephant") on June 17, 2026, regarding its filing of a Notice of Civil Claim in Vancouver, British Columbia. The allegations contained in Silver Elephant's news release and its Notice of Civil Claim are spurious and wholly without merit, and Andean strongly disagrees with Silver Elephant's characterization of the facts and circumstances described therein.

Neutral

General

APM: Neutral

GlobeNewsWire•6/10/2026

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

NEW YORK, NY, June 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company dedicated to addressing unmet medical needs, today announced that at its shareholder meeting held on June 9, 2026, its shareholders voted to approve the proposed merger transaction with DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases.

Neutral

General

APM: Neutral

Supply Chain of APM

RELATIONS

Upstream

Covar PharmaceuticalsA*ccelerate Technologies Pte LtdAgency for Science, Technology and Research (A*STAR)University of Hong Kong (HKU)Contract Manufacturing Organization (Canada) — UnnamedClinical Research Organization (CRO) — UnnamedJurchen Investment CorporationJADBio

Downstream

HKTV Mall (Hong Kong Technology Venture Company Limited)HKEx:1137DiamiR Biosciences Corp.NativusWell Official Website (nativuswell.com)

Proxies

DiamiR Biosciences Corp.UnconfirmedAptorum Therapeutics Limited (ATL)UnconfirmedHKTVmall (Hong Kong Technology Venture Company Limited)HKEx:1137

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer